Cellosaurus HepG2/Adm (CVCL_M187)
| Cell line name | HepG2/Adm |
|---|---|
| Synonyms | HepG2/ADM; Hep-G2/ADM; Hep G2/ADM |
| Accession | CVCL_M187 |
| Resource Identification Initiative | To cite this cell line use: HepG2/Adm (RRID:CVCL_M187) |
| Comments | Population: Caucasian. Doubling time: 30.1 hours (PubMed=15087025). Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
| Sequence variations |
|
| Disease | Hepatoblastoma (NCIt: C3728) Hepatoblastoma (ORDO: Orphanet_449) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0027 (Hep-G2) |
| Sex of cell | Male |
| Age at sampling | 15Y |
| Category | Cancer cell line |
| Publications | PubMed=14980111 PubMed=15087025 PubMed=17075973; DOI=10.3748/wjg.v12.i41.6614; PMCID=PMC4125665 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_M187 |
| Anatomy/cell type resources | BTO; BTO_0006029 |
| Chemistry resources | ChEMBL-Cells; CHEMBL4482252
PubChem_Cell_line; CVCL_M187 |
| Encyclopedic resources | Wikidata; Q54882859 |
| Entry history | |
| Entry creation | 06-May-2013 |
| Last entry update | 27-Nov-2025 |
| Version number | 20 |